Related Experiment Video
Updated: Jul 18, 2026

10:10
A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Pulmonary and peritoneal tuberculosis in a CAPD patient
Basol Canbakan1, Ihsan Ergun, Yakup Ekmekci
1Department of Nephrology, Ibni Sina Hospital, Ankara University School of Medicine, Sihhiye, Ankara, 06100, Turkey.
International Urology and Nephrology
|December 14, 2006
Summary
Patients with chronic renal failure are at higher risk for tuberculosis. This case highlights a rare instance of simultaneous pulmonary and tuberculous peritonitis in a continuous ambulatory peritoneal dialysis patient.
Area of Science:
- Nephrology
- Infectious Diseases
- Pulmonology
Background:
- Patients with chronic renal failure exhibit diminished cellular immunity, increasing tuberculosis susceptibility.
- Extrapulmonary tuberculosis is prevalent in over half of these patients.
- Tuberculous peritonitis poses a significant challenge for individuals on continuous ambulatory peritoneal dialysis (CAPD).
Observation:
- A 39-year-old male on CAPD presented with culture-negative peritonitis, unresponsive to standard antimicrobial treatment.
- Symptoms included persistent fever, weight loss, and night sweats.
- After one month, both sputum and peritoneal fluid cultures confirmed Mycobacterium infection.
Findings:
- The patient was initiated on quadruple tuberculosis therapy.
- Prompt clinical improvement was observed following the initiation of antitubercular treatment.
- The patient successfully continued CAPD while undergoing treatment.
Implications:
- Culture-negative peritonitis in CAPD patients unresponsive to conventional antibiotics warrants investigation for tuberculous peritonitis.
- Simultaneous pulmonary and peritoneal tuberculosis, though rare, should be considered in the differential diagnosis.
- Thorough investigation for extraperitoneal tuberculosis, particularly pulmonary involvement, is crucial in such cases.
Related Concept Videos
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories: